Invasive Ductal Carcinoma - Morphofunctional (USA)

40 year old lady. With the puttable lamp in the right breast. The synthetic views. Show dance activity at the genius breasts with no significant lesions. If we move. To the Tomo study. Then we can see and subtle architectural distortion. In the right breast. Not clearly detected. In the e-mail of you. Then. If we focus. In this mission. We can. See perfectly and irregular spiculated mass. By using the thermal spot compression. And finally, we perform a Tyson study showing this enhancing mass. That is not clearly detective on. The conventional mammography. The correlation with. MRI was very nice showing. And advancing Mars. And and strong breast parenchymal parenchymal enhancement. The result of the biopsy was an invasive ductal carcinoma luminal B subtype. So if we compare tomosynthesis and Tyson in dense breasts, we can see that Tyson has a morpho functional technique was superior. Than tomosynthesis.

11 12/2/2020 Preoperative 1 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS 11_PreOp_1, PID3642 * 1/1/2022 F PID3642 Series Navigator INSIGHT_2D PID3642 11/1/2020 (Study date) Current INSIGHT 2D_RCC TRMLO TRCC ¥MG, 11/1/2020 n.a ., 17 mo ... Mamografia unilateral con contraste Viewing Favorite Layouts US MR DYN PC.MLOICC MR.Dyna ... IN 2D MR.Empty ReportFlow BASIC Printing Tools Findings MR 5:19 PM Add Study Clinical information 40-year-old female Palpable lump in the right breast C.US | C .... Healthineers LCC Slice 21 / 46 Slice 32 / 45 Slice thickness: 1.00 mm LMLO Current Current Slice 23 / 50 Slice 25 / 47 SIEMENS . Slice thickness: 1.00 mm |Slice thickness: 1.00 mm RCC LowEnergy Recombined Subtraction 3:16:02 PM MG, 11/1/2020 n.a ., 17 mo ... 1976 IMA 71 INSIGHT_CEM_RCC Unsupported, 11/1/2020 n.a ... SL 1.5 mm SP F25.0 p2 1/1/2022, F C.CC 9:41 PM 1 PM 9:42 PM 5:20 PM Pathology Invasive ductal carcinoma (IDC) Luminal B Conclusion TiCEM, as a morphofunctional imaging technique, was superior to DBT in a very dense breast. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations.